Markets:

Overview

News

Currencies

International

Treasuries

Pasithea Therapeutics Corp. - Common Stock (NQ:KTTA)

0.8010 +0.0023 (+0.29%)

Streaming Delayed Price Updated: 10:44 AM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pasithea Therapeutics Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

EXCLUSIVE: Pasithea Expands Its Core Therapeutic Pipeline With This Acquisition ↗

June 22, 2022

Pasithea Therapeutics Corp (NASDAQ: KTTA) has acquired Alpha-5 integrin LLC, a privately-held preclinical-stage company developing a monoclonal antibody (mAbs) for amyotrophic lateral sclerosis (ALS)...

Via Benzinga

PsychedelicNewsBreaks – Pasithea Therapeutics Corp.’s (NASDAQ: KTTA) CEO Featured in Forbes Article

May 05, 2022

Via Investor Brand Network

Pasithea Biotech Reports That It's Aiming To Be At The Forefront Of The Mental Health Revolution ↗

April 25, 2022

Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Virtual Reality Technologies Are Reportedly Unlocking New Possibilities For Mental Healthcare ↗

April 18, 2022

Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 17, 2022

On Tuesday, 123 stocks made new 52-week lows.

Via Benzinga

Pasithea Reveals Cash Position Of $52.9 Million In Latest Earnings Report, To Expand Pipeline And Fund Operations Well Into 2024 ↗

April 01, 2022

Image sourced from Pixabay

Via Benzinga

This Ketamine-Assisted Therapy Company Is Developing New Ways To Treat Alcohol Addiction ↗

March 24, 2022

Picture credit: Martin Sanchez on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 15, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) stock moved upwards by 92.3% to $44.04 during Tuesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

Pasithea Partners With Glimpse Group To Co-Develop VR Environments For Patients With Psychiatric Disorders ↗

March 10, 2022

Photo by Maxim Hopman on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....

Via Benzinga

Rising Number of Mental Health Disorders Fuel Advancing Initiatives to Reduce Psychiatric and Neurological Conditions

March 08, 2022

Palm Beach, FL –– March 8, 2022 – FinancialNewsMedia.com News Commentary – According to a report from Grand View Research “High unmet medical needs and government initiatives to reduce the psychiatric...

Via FinancialNewsMedia

Topics Economy

EXCLUSIVE: Glimpse-Pasithea To Co-Develop VR Environments For Patients With Psychiatric Disorders ↗

March 08, 2022

Pasithea Therapeutics Corp (NASDAQ: KTTA) has partnered with Glimpse Group Inc (NASDAQ: VRAR), a Virtual Reality and Augmented Reality (VR / AR) platform company, and its...

Via Benzinga

This Company Reports Using Ketamine To Treat Mental Health Disorders ↗

March 07, 2022

Photo by Sydney Sims on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice....

Via Benzinga

Pasithea To Open 3 New Clinics In The U.K. For Patients with Mental Health Issues, Each Clinic Expected To Add ~$5 Million In Annual Revenue ↗

February 25, 2022

Image by Christina on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Pasithea...

Via Benzinga

Pasithea Therapeutics Announces Plans To Open Three New Clinics In The UK By Mid-2022 ↗

February 24, 2022

-- Each clinic expected to contribute an estimated USD$5 million (£4 million) annually in revenue -- -- New London locations will provide pharmacy services, ketamine therapy...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 03, 2022

Gainers Cidara Therapeutics (NASDAQ:CDTX)...

Via Benzinga

Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally

February 24, 2022

Palm Beach, FL –– February 24, 2022 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not kept...

Via FinancialNewsMedia

Global Multiple Sclerosis Drugs Market Expected to Reach $41.99 Billion in 2028

February 03, 2022

Palm Beach, FL –– February 3, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system. It is characterized by demyelination,...

Via FinancialNewsMedia

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 03, 2022

Gainers SOC Telemed (NASDAQ:TLMD) shares increased by 338.2% to $2.82 during Thursday's pre-market session. The market value of their outstanding shares is at $284.5...

Via Benzinga

EXCLUSIVE: Pasithea Therapeutics Starts New Multiple Sclerosis Vaccine Development Program ↗

February 03, 2022

Pasithea Therapeutics Corp (NASDAQ: KTTA) has announced a new chemical entity (NCE) development program and named Massachusetts-based Hooke Laboratories as its research partner.

Via Benzinga

From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances ↗

January 05, 2022

Photo by David Matos on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

Mobile Clinics for Mental Health Treatments Reportedly Launching in Major Cities Across the U.S. ↗

December 28, 2021

Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

December 27, 2021

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY...

Via Benzinga

51 Biggest Movers From Yesterday ↗

December 28, 2021

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; News Corp To Buy Base Chemicals ↗

December 27, 2021

Following the market opening Monday, the Dow traded up 0.39% to 36,089.53 while the NASDAQ rose 0.78% to 15,774.78. The S&P also rose, gaining 0.70% to 4,758.97. The U.S. has...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:

Via Benzinga

54 Biggest Movers From Thursday ↗

December 27, 2021

Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

December 23, 2021

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK....

Via Benzinga

Casino Stocks: Why LVS, MLCO and WYNN Are Getting Buy-In Today ↗

December 23, 2021

Casino stocks are on the move today thanks to a recent report out of China's Macau concerning new government regulations.

Via InvestorPlace

KTTA Stock Alert: 6 Things to Know About Pasithea Therapeutics as Shares Soar Today ↗

December 23, 2021

Pasithea Therapeutics (KTTA) stock is heading higher on heavy trading Thursday even without any recent news from the biotech company.

Via InvestorPlace

EXCLUSIVE: What's Going On With Pasithea Therapeutics Stock Today? ↗

December 23, 2021

Pasithea Therapeutics Corp (NASDAQ: KTTA) is trading higher on abnormally-high volume Thursday. Pasithea Therapeutics' average session volume is about 2.6 million over a 100-...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.